ALK Inhibition | ALK Inhibitor Review sorted by
relevance

Admin21.09.2021

ALK Inhibition | ALK Inhibitor Review

5603
Admin01.08.2021

GSK3 and ALK inhibition affect migration in neuroblastoma

405
Admin03.09.2021

Phosphoproteomic analysis after ALK inhibition in CLB-BAR

89010
Admin01.09.2021

(PDF) Early and late effects of pharmacological ALK

3206
Admin22.07.2021

Effects of ALK inhibition in the EML4-ALK-positive NSCLC

8002
Admin20.07.2021

Gene Set Enrichment Analysis (GSEA) with the hallmarks and

1009
Admin02.08.2021

ALK inhibition experimental setup. (A) Three different

8305
Admin25.08.2021

ALK inhibition does not affect mTORC1 signaling in MYCN

47010
Admin07.08.2021

ALK inhibition-dependent attenuation of BaF3/NPM-ALK cell

5906
Admin30.09.2021

ALK inhibition experimental setup. (A) Three different

806
Admin25.07.2021

Phosphoproteomic analysis after ALK inhibition in CLB-BAR

7908
Admin27.08.2021

Precursor model-fitted and observed ALK inhibition by

68010
Admin18.09.2021

ALK inhibition-dependent attenuation of BaF3/NPM-ALK cell

2309
Admin13.07.2021

ALK Suppresses the Expression of DLG2 through the MAPK

18010
Admin11.09.2021

Insulin-like growth factor (IGF)-1 and ALK inhibition

Admin06.09.2021

Response to ALK inhibition: percent change in tumor burden

1507
Admin16.07.2021

Frontiers | ALK Inhibitors, a Pharmaceutical Perspective

6004
Admin20.08.2021

Antihypertrophic effect of Fstl3 knockdown can be reversed

10010
Admin05.09.2021

Indirect-response model-fitted and observed ALK inhibition

7302
Admin27.07.2021

(PDF) Phosphoproteome and gene expression profiling of ALK

8502
Admin24.08.2021

ALK inhibition does not affect mTORC1 signaling in MYCN

6303